Evidence map›Paper›PMID 27167204›Full record

ArticleOncotarget2016

GDNF secreted from adipose-derived stem cells stimulates VEGF-independent angiogenesis.

Zhaohui Zhong, Huiying Gu, Jirun Peng, Wenzheng Wang, Brian H Johnstone, Keith L March, Martin R Farlow, Yansheng Du

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Nervous System-Driven Osseointegration.International journal of molecular sciences · 2022
    Review
  6. Review
  7. CD73Annals of translational medicine · 2022
    Article
  8. Frontiers in microbiology · 2022
    Article
  9. Article
  10. Article
  11. Posttranscriptional control ofAnnals of translational medicine · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Zhaohui ZhongDepartment of General Surgery, Peking University People's Hospital, Beijing 100044, PR China.
Huiying GuDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Jirun PengDepartment of Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, PR China.
Wenzheng WangDepartment of General Surgery, Peking University People's Hospital, Beijing 100044, PR China.
Brian H JohnstoneDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Keith L MarchDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Martin R FarlowDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Yansheng DuDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Indiana University – Purdue University Indianapolis · USBeijing Shijitan Hospital · CNPeking University · CNPeking University People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipose tissue stroma contains a population of mesenchymal stem cells (MSC) promote new blood vessel formation and stabilization. These adipose-derived stem cells (ASC) promote de novo formation of vascular structures in vitro. We investigated the angiogenic factors secreted by ASC and discovered that glial-derived neurotrophic factor (GDNF) is a key mediator for endothelial cell network formation. It was found that both GDNF alone or present in ASC-conditioned medium (ASC-CM) stimulated capillary network formation by using human umbilical vein endothelial cells (HUVECs) and such an effect was totally independent of vascular endothelial growth factor (VEGF) activity. Additionally, we showed stimulation of capillary network formation by GDNF, but not VEGF, could be blocked by the Ret (rearranged during transfection) receptor antagonist RPI-1, a GDNF signaling inhibitor. Furthermore, GDNF were found to be overexpressed in cancer cells that were resistant to the anti-angiogenic treatment using the VEGF antibody. Cancer cells in the liver hepatocellular carcinoma (HCC), a non-nervous related cancer, highly overexpressed GDNF as compared to normal liver cells. Our data strongly suggest that, in addition to VEGF, GDNF secreted by ASC and HCC cells, may be another important factor promoting pathological neovascularization. Thus, GDNF may be a potential therapeutic target for HCC and obesity treatments.

Indexed as

AdipocytesAdipose TissueCarcinoma, HepatocellularCell Line, TumorGlial Cell Line-Derived Neurotrophic FactorHumansHuman Umbilical Vein Endothelial CellsLiver NeoplasmsMesenchymal Stem CellsNeovascularization, PathologicVascular Endothelial Growth Factor AGDNF protein, humanGlial Cell Line-Derived Neurotrophic FactorVascular Endothelial Growth Factor AVEGFA protein, humanangiogenesisASC-CMGDNFhepatocellular carcinomaVEGF

Identifiers

PMID27167204
PMCPMC5095042
OpenAlexW2345717795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.